RC
Insider
Rebecca Chambers
Chief Financial OfficerRebecca Chambers (Chief Financial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Veracyte, Inc. (VCYT). The largest single filing was $663K of VCYT (18,341 sh across 2 lots, as filed), executed Mar 4.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.7M
shares × price, as filed
Last traded
Sep 4
Filed Sep 4
Median ADV $55.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
VCYTRecent filings
VCYTSALE
Veracyte, Inc.
View filing →
$106K2,477 sh × $42.81
Exec Sep 4
Filed Sep 4 · 7:54 PM ET VCYTSALE Veracyte, Inc. View filing → $663K
18,341 sh across 2 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $622K
13,278 sh across 2 lots
Exec Dec 4 2025
Filed Dec 4 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $287K
7,000 sh × $41.00
Exec Nov 5 2025
Filed Nov 7 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $303K
7,000 sh × $43.23
Exec Dec 3 2024
Filed Dec 4 2024 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $586K
15,275 sh × $38.34
Exec Nov 12 2024
Filed Nov 14 2024 · 5:30 PM ET